Fulminant Hepatic Failure Secondary to Primary Hepatic Angiosarcoma

Table 1

Laboratory tests two months prior to presentation, at presentation, and at the time of patient’s death.

Laboratory tests	Normal range	2 months prior to presentation	At presentation	Time of death
Liver function tests
Total bilirubin	0.3–1.2 mg/dL	0.9	9.8	27
Direct bilirubin	0–0.3 mg/dL	0.2	6.3	18.5
Alkaline phosphatase	36–92 U/L	81	383	1120
Gamma-glutamyl transferase	0–30 U/L	58	701	1200
Aspartate aminotransferase	0–35 U/L	25	104	5522
Alanine aminotransferase	0–35 U/L	21	206	2313
Prothrombin time	11–13 sec	14.1	14.8	43.2
Partial thromboplastin time	25–35 sec	27.5	34.6	69.9
International normalized ratio		1.10	1.16	4.97
Lactate dehydrogenase (LDH)	60–100 U/L	190	451	20000
Peripheral blood cell count
Hemoglobin, g/L	12.6–16.8	14.4	14.1	5.5
White blood cell count, /L	3.7–10.5 × 10^9	5.4	6.5	26
Platelet count, /L	167–400 × 10^9	144	143	22
Blood chemistry
Sodium, mmol/L	135–144	145	139	123
Potassium, mmol/L	3.5–5	4.6	5.1	5.4
Chloride, mmol/L	100–110	110	104	95
Bicarbonate, mmol/L	23–31	24	24	10
Blood urea nitrogen, mmol/L (mg/dL)	2.85–7.14 (7.98–20)	15	20	80
Creatinine, mmol/L (mg/dL)	53.0–123.7 (0.6–1.4)	0.8	1.2	6.3